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Abstract
Background: The pathological mechanisms of lumbar spinal stenosis are unclear. Family doctors in the primary
care setting may perform medical examinations of patients with lumbar spinal stenosis. Our aim was to use the
painDETECT questionnaire to quantify the pathological mechanisms of low back pain and/or leg pain caused by
lumbar spinal stenosis.
Methods: We enrolled 102 patients (37 men, 65 women) who had been newly diagnosed with lumbar spinal
stenosis at 2 facilities. The patients’ conditions were evaluated using the painDETECT questionnaire, Numerical
Rating Scale, Roland-Morris Disability Questionnaire, Japanese Orthopaedic Association Back Pain Evaluation
Questionnaire, and 36-Item Short-Form Health Survey. The pathological mechanisms of low back pain and/or
leg pain caused by lumbar spinal stenosis were classified based on results of the painDETECT questionnaire as
nociceptive pain, neuropathic pain, or unclear type of pain (mixed pain). Statistical analyses were performed
using the Kruskal–Wallis test. A value of p < 0.05 was considered to indicate statistical significance.
Results: The mean age of all patients in this study was 70.3 ± 2 years. The male:female distribution was 37:65
(36.3:63.7 %). In all, 72 (70.6 %) patients had chronic pain (duration of ≥3 months), and 30 (29.4 %) had subacute
or acute pain (duration of <3 months). The pain was classified as nociceptive in 59 patients (57.9 %), neuropathic in
18 (17.6 %), and unclear in 25 (24.5 %). The neuropathic pain group had a significantly lower quality of life (p < 0.05)
than did the other groups.
Conclusions: Patients with neuropathic back and/or leg pain caused by lumbar spinal stenosis may have lower
physical and/or psychological quality of life than patients with such pain caused by other mechanisms.
Keywords: Lumbar spinal stenosis, Nociceptive pain, Neuropathic pain, Cross-sectional study, painDETECT
questionnaire, Numerical rating scale, Roland–Morris Disability Questionnaire score, Japanese Orthopaedic
Association Back Pain Evaluation Questionnaire, 36-Item Short-Form Health Survey, Primary care
Background
Lumbar spinal stenosis (LSS) is the one of the most
commonly encountered orthopedic disorders. Family
doctors in the primary care setting may perform medical
examinations of patients with LSS. Therefore, an under-
standing of the pathological mechanisms of LSS may be
very helpful for these doctors.
LSS is defined as a reduction in the area of the spinal
canal, lateral canal, and/or foramina. Symptoms of LSS
may occur as a result of neurovascular mechanisms
[1–3], such as reduced arterial flow in the cauda
equina, venous congestion, increased epidural pres-
sure, nerve root infiltration, and direct compression in
the central canal and/or lateral recess [4]. Although
the characteristic symptom of LSS is neurogenic inter-
mittent claudication (NIC) [5, 6], other symptoms may
appear as well, including low back pain (LBP), radicu-
lar pain and/or numbness down the leg, and motor
weakness in the legs [7–10]. It is therefore important
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to analyze the pathological mechanisms of LBP and/or
leg pain caused by LSS to alleviate the symptoms.
We considered the pain mechanisms according to a
classification that included neuropathic pain, nociceptive
pain, and mixed pain [11, 12]. Neuropathic pain is defined
by the International Association for the Study of Pain as
“pain initiated or caused by a primary lesion or dysfunc-
tion of the nervous system” [13]. It may be associated with
abnormal sensations called dysesthesia or produced by
normally nonpainful stimuli such as allodynia. Nociceptive
pain may also be a result of the encoding and processing
of harmful stimuli in the nervous system, reflecting the
ability of the body to sense potential harm [14]. Because
the developmental mechanisms responsible for neuro-
pathic and nociceptive pain differ, treatment plans differ
as well. Therefore, the pathological mechanisms of the
pain should be precisely identified to arrive at an exact
diagnosis of LSS-derived LBP and/or leg pain.
A recent study using the painDETECT questionnaire
demonstrated that neuropathic pain was less common in
patients with chronic LBP and that patients with neuro-
pathic back and/or leg pain reported significantly more
pain, disability, anxiety, depression, and reduced quality
of life (QOL) than patients with nociceptive pain [15].
The pathological mechanisms of LSS, however, were un-
clear. Few studies have used the painDETECT question-
naire to quantify the pathological mechanisms of LSS
[16, 17]. The purpose of this study was to quantify the
pathological mechanisms of LBP and/or leg pain caused
by LSS using the painDETECT questionnaire, and to re-
port quality of life data in patients with LSS. This study
may help to fully elucidate the epidemiology of LSS-
derived LBP and/or leg pain in the primary care setting.
Methods
The ethics committees of the participating research insti-
tutions approved this study. Written informed consent
was obtained from all patients prior to their participation.
This cross-sectional multicenter observational study
was conducted nationwide at two hospitals with their
attending spinal surgeons. The recruitment period was
1.5 years (1 April 2013 to 30 September 2014).
Patients
The study group included 102 consecutive patients (37
men, 65 women) who were newly diagnosed with LSS at
two facilities: Aizu Medical Center Fukushima Medical
University and the Fukushima Prefectural Minami-Aizu
Hospital. Three spinal surgeons diagnosed the patients
with LSS based on magnetic resonance imaging (MRI)
findings of LSS, subjective symptoms, and neurological
findings. All of the patients had subjective symptoms
that included leg symptoms, LSS-related neurological
findings, and MRI evidence of LSS. An independent
radiologist assessed the MRI scans obtained for each
patient at the time of diagnosis for evidence of LSS, in-
cluding central, lateral recess, and foraminal stenosis.
The MRI diagnosis of LSS was based on the following
findings: (1) blockage of cerebrospinal fluid and/or the
disappearance of fatty tissue surrounding the foramen
on T1-weighted images in the sagittal view; (2) central
stenosis, lateral recess stenosis, and/or foraminal sten-
osis caused by lumbar disc compression from the front,
and/or increased size of the ligamentum flavum, and/or
articular factors from the back in the axial view; and/or
(3) compression of the nerve root surrounding the foramen
in the coronal view. The ankle-brachial pressure index
(ABI) was also checked in all patients to distinguish
NIC from vascular intermittent claudication (ABI <0.9).
The ABI is the systolic pressure at the ankle divided by
the systolic pressure at the arm. It has been shown to
be a specific and sensitive metric for the diagnosis of
peripheral arterial disease [18].
The inclusion criteria for all patients were (1) a diagno-
sis of lumbar spondylosis, degenerative spondylolisthesis,
or degenerative scoliosis with LSS; (2) pain and/or numb-
ness in the lumbar dermatomal distribution; (3) motor or
sensory neurological signs (hypoesthesia, hyperesthesia,
allodynia, or dysesthesia) in the affected dermatomes;
(4) cognitive capability to satisfy our inquiries; and (5)
neurogenic NIC due to LSS. The exclusion criteria for
all patients were (1) diagnosis of lumbar degenerative
disease without LSS; (2) predominantly axial spinal pain;
(3) rheumatoid arthritis; (4) known peripheral neuropathy;
(5) history of workmen’s compensation or disability issues;
(6) chronic depression and use of antidepressant medi-
cation; and (7) patients with an ABI of <0.9.
Methods
The painDETECT neuropathic pain screening question-
naire scores [17] were used to identify the three pain
subgroups of patients with LBP and/or leg pain caused
by LSS: (1) those with nociceptive pain, (2) those with
neuropathic pain, and (3) those in whom the type of
pain was unclear [15, 19]. We used the Japanese version
of the painDETECT neuropathic pain screening ques-
tionnaire score [20]. The cut-off values for categorizing
the type of pain based on the painDETECT neuropathic
pain screening questionnaire scores were as follows:
nociceptive pain, 0–12; unclear type of pain (mixed
nociceptive and neuropathic pain), 13–18; and neuro-
pathic pain, 19–38. The painDETECT neuropathic pain
screening questionnaire is a reliable screening tool with
high sensitivity, high specificity, and positive predictive
accuracy. These parameters were each 84 % in a palm-
top computerized version of the questionnaire and 85,
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80, and 83 %, respectively, in a corresponding pencil-
and-paper questionnaire [17]. Matsubayashi et al. [20]
demonstrated that the Japanese version of the pain-
DETECT neuropathic pain screening questionnaire
has good validity and reliability, similar to that found
with the original version.
Numerical rating scale (NRS) and Roland-Morris
Disability Questionnaire (RDQ) scores [21] were used
to compare the severity of subjective symptoms and
the QOL associated with LBP at the patient’s first med-
ical examination. The patients used the NRS for self-
evaluation of their leg pain and/or numbness. Both the
NRS and RDQ scores were evaluated at the time of the
first medical examination. We used the Japanese ver-
sion of the RDQ score [22].
The Japanese Orthopaedic Association Back Pain
Evaluation Questionnaire (JOABPEQ) [23, 24] and the
36-Item Short-Form Health Survey (SF-36) [25] were
used to compare the severity of subjective symptoms
and the QOL associated with LBP and health at the
patient’s first medical examination. The JOABPEQ has
five subscales, and the SF-36 has eight. For both ques-
tionnaires, higher scores indicate better QOL. We
used the Japanese version of the SF-36 [26, 27]. The
SF-36 uses scores of 0 to 100, but the scores are not
based on the norm.
The primary outcome was the type of pain—nocicep-
tive, neuropathic, or unclear (mixed)—in patients with
LBP and/or leg pain caused by LSS. At the first medical
examination, we compared the patients’ demographic
and clinical characteristics; NRS (LBP); NRS (leg pain,
leg numbness); and RDQ, JOABPEQ, and SF-36 scores
among the three pain groups using the Kruskal–Wallis
test. We also compared these outcomes according to the
duration of symptoms—i.e., <3 months (acute and/or
subacute phase) or ≥3 months (chronic phase) after the
onset of LBP and/or leg pain caused by LSS. A p value
of <0.05 was considered to indicate statistical signifi-
cance. The statistical analyses were performed using
StatView 5.0 statistical software (SAS Institute, Cary,
NC, USA). The statistical power analysis of this study
was performed using G*Power 3.1 (Heinrich-Heine-
Universität Düsseldorf, Düsseldorf, Germany) [28]. The
power analysis utilized an effect size of 0.4, alpha level
of 0.05, power (1 − beta error probability) of 0.95, and
requirement of three groups. Finally, the total required
sample size was calculated as 102.
Ethics
This study was approved by the ethics committees of the
two participating research institutions: Aizu Medical
Center Fukushima Medical University and Fukushima
Prefectural Minami-Aizu Hospital. Informed consent
was obtained from all patients.
Results
The mean age of all patients (n = 102) in this study was
70.3 ± 2 years. The male:female distribution was 37:65
(36.3:63.7 %). The NIC was radicular in 68.6 % (n = 70),
caudal in 8.8 % (n = 9), and mixed in 22.6 % (n = 23).
Spinal stenosis seen by MRI appeared at one level in
41.4 % (n = 42), two levels in 43.1 % (n = 44), and three
levels in 11.7 % (n = 12). The causes of LSS were lumbar
spondylitis in 55.0 % (n = 56), degenerative spondylo-
listhesis in 33.3 % (n = 34), and degenerative scoliosis in
11.7 % (n = 12).
The demographic and clinical characteristics of the pa-
tients with LBP and/or leg pain caused by LSS for each
pain subgroup are shown in Table 1. The demographic
and clinical characteristics of the patients with LBP and/
or leg pain caused by LSS were similar among the three
pain subgroups.
Among all patients with LBP and/or leg pain caused
by LSS, 59 (57.9 %) had nociceptive pain, 18 (17.6 %)
had neuropathic pain, and 25 (24.5 %) had an unclear
type of pain (mixed pain) at their first medical examin-
ation (Table 2). In all, 72 (70.6 %) patients had chronic
pain (duration of ≥3 months), and 30 (29.4 %) had sub-
acute or acute pain (duration of <3 months). Among the
patients whose LBP and/or leg pain caused by LSS had
been present for ≥3 months, 41 (56.9 %) had nociceptive
pain, 14 (19.5 %) had neuropathic pain, and 17 (23.6 %)
had pain of unclear (mixed pain) at their first medical
examination (Table 2). Among those whose LBP and/or
leg pain caused by LSS had been present for <3 months,
18 (60.0 %) patients had nociceptive pain, 4 (13.3 %) had
neuropathic pain, and 8 (26.7 %) had unclear pain
(mixed pain) at their first medical examination (Table 2).
The populations of the three pain subgroups [nocicep-
tive, neuropathic, and unclear (mixed)] with LBP and/or
leg symptoms caused by LSS (regardless of pain duration)
were thus similar.
NRS scores for LBP, leg pain, and leg numbness in pa-
tients with LBP and/or leg pain caused by LSS were not
significantly different among the three pain groups
(Table 3). However, the RDQ score in patients with LBP
and/or leg pain caused by LSS was significantly lower
in the neuropathic pain group than in the other groups
(p < 0.05) (Table 3). In contrast, there were no signifi-
cant differences among the three pain groups regarding
(1) the NRS scores for LBP, leg pain, or leg numbness
or (2) the RDQ scores in patients with LBP and/or leg
pain caused by LSS that had been present for ≥3 months
or <3 months (Table 3).
The five JOABPEQ subscales were LBP, lumbar func-
tion, walking ability, social life function, and mental
health. The eight SF-36 subscales were physical func-
tioning, physical role functioning, bodily pain, general
health perceptions, vitality, emotional functioning, social
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role functioning, and mental health. The subscale scores
of both questionnaires for each pain group are shown in
Tables 4 and 5. There were statistically significant diffe-
rences in three JOABPEQ subscales [lumbar function,
social life function, and mental health (p < 0.05)] and in
two SF-36 subscales [physical function and bodily pain
(p < 0.05)] (Tables 4 and 5). In regard to pain duration,
for patients whose pain had been present for ≥3 months
after the onset of symptoms, there were statistically sig-
nificant differences in two JOABPEQ subscales [lumbar
function and mental health (p < 0.05)], but no statisti-
cally significant differences in any of the SF-36 subscales
(Tables 4 and 5). For patients whose pain had been
present for <3 months after the onset of symptoms,
there were no statistically significant differences in any
of the JOABPEQ subscales (p < 0.05), but there was a
statistically significant difference in one SF-36 subscale
[bodily pain (p < 0.05)] (Tables 4 and 5).
Table 1 Demographic and clinical characteristics at the first medical examination
Characteristic Nociceptive pain Type of pain unclear
(mixed pain)
Neuropathic pain pa
Age (years) 71.4 ± 1.36 69.0 ± 2.34 68.3 ± 2.91 0.720
Sex 0.572
Male 18 11 8
Female 41 14 10
Duration of pain 0.914
≧3 months 41 17 14
<3 months 18 8 4
Affected spinal level 0.730
L3–L4 18 9 3
L4–L5 36 16 15
L5–S1 5 0 0
NIC type 0.668
Radicular 41 15 14
Caudal 5 4 0
Mixed 13 6 4
Spinal stenosis levels involvedb 0.373
1 28 8 6
2 25 11 8
≥3 6 6 4
Cause of LSS 0.672
Lumbar spondylitis 30 15 11
Degenerative spondylolisthesis 20 8 6
Degenerative scoliosis 9 2 1
The demographic and clinical characteristics of the patients with LBP and/or leg pain caused by LSS were similar among the three pain subgroups
LBP low back pain, LSS lumbar spinal stenosis, NIC neurogenic intermittent claudication, LDH lumbar disc degeneration, MRI magnetic resonance imaging
aKruskal–Wallis test
bSeen on MRI
Table 2 painDETECT questionnaire scores at the first medical
examination
Origin of pain Patients, n (%)
Total patients 102 (100)
Nociceptive pain 59 (57.9)
Type of pain unclear (mixed pain) 25 (24.5)
Neuropathic pain 18 (17.6)
Group with pain present ≥3 months
Nociceptive pain 41 (56.9)
Type of pain unclear (mixed pain) 17 (23.6)
Neuropathic pain 14 (19.5)
Group with pain present <3 months
Nociceptive pain 18 (60.0)
Type of pain unclear (mixed pain) 8 (26.7)
Neuropathic pain 4 (13.3)
LBP low back pain, LSS lumbar spinal stenosis
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Table 3 NRS and RDQ scores at the first medical examination
Parameter Nociceptive pain Type of pain unclear (mixed pain) Neuropathic pain pa
Total patients with pain at first examination
NRS (low back pain) 4.75 ± 0.433 5.88 ± 0.561 6.39 ± 0.691 0.099
NRS (leg pain) 5.59 ± 0.397 6.72 ± 0.618 6.39 ± 0.687 0.205
NRS (leg numbness) 4.88 ± 0.422 5.56 ± 0.651 6.83 ± 0.556 0.101
RDQ 9.00 ± 0.760 9.52 ± 1.16 6.68 ± 1.57 0.025a
Group with pain present ≥3 months
NRS (low back pain) 5.27 ± 0.523 6.12 ± 0.587 6.43 ± 0.724 0.462
NRS (leg pain) 5.61 ± 0.479 6.35 ± 0.722 6.57 ± 0.685 0.566
NRS (leg numbness) 5.49 ± 0.513 5.82 ± 0.666 6.50 ± 0.618 0.713
RDQ 9.66 ± 0.952 8.82 ± 1.41 13.7 ± 1.77 0.074
Group with pain present <3 months
NRS (low back pain) 3.56 ± 0.715 5.38 ± 1.28 6.25 ± 2.06 0.275
NRS (leg pain) 5.56 ± 0.729 7.50 ± 1.20 5.75 ± 2.18 0.275
NRS (leg numbness) 3.50 ± 0.643 5.00 ± 1.52 8.00 ± 1.23 0.060
RDQ 7.50 ± 1.19 11.0 ± 2.09 13.5 ± 3.97 0.125
Data are shown as mean ± standard error
The NRS scores of LBP, leg pain, and leg numbness in patients with LBP and/or leg pain caused by LSS were not significantly different among the three pain
groups. However, the RDQ score in patients with LBP and/or leg pain caused by LSS was significantly lower in the neuropathic pain group than in the other
groups (p < 0.05)
NRS numerical rating scale, RDQ Roland–Morris Disability Questionnaire
aKruskal–Wallis test
Table 4 JOABPEQ score for each pain type at the first medical examination
Parameter Nociceptive pain Type of pain unclear (mixed pain) Neuropathic pain pa
Total patients with pain at first examination
Low back pain 50.8 ± 4.21 41.1 ± 7.30 30.9 ± 6.94 0.071
Lumbar function 66.1 ± 3.66 64.9 ± 5.29 37.0 ± 7.80 0.005a
Walking ability 44.8 ± 4.06 40.0 ± 4.37 35.3 ± 6.66 0.580
Social life function 50.6 ± 2.99 36.8 ± 3.45 42.8 ± 5.79 0.015a
Mental health 49.4 ± 2.47 40.6 ± 3.54 39.8 ± 5.17 0.048a
Group with pain present ≥3 months
Low back pain 48.1 ± 5.07 41.1 ± 8.23 29.6 ± 8.13 0.188
Lumbar function 63.6 ± 4.91 65.1 ± 6.87 38.1 ± 8.56 0.033a
Walking ability 42.6 ± 5.04 39.5 ± 6.00 36.7 ± 7.06 0.881
Social life function 49.5 ± 3.91 35.5 ± 4.30 44.1 ± 6.79 0.064
Mental health 52.5 ± 2.81 41.1 ± 4.42 40.7 ± 5.60 0.032a
Group with pain present <3 months
Low back pain 57.2 ± 7.55 41.0 ± 15.6 35.8 ± 14.8 0.373
Lumbar function 71.8 ± 4.24 64.5 ± 8.42 33.3 ± 20.8 0.172
Walking ability 49.7 ± 6.80 41.3 ± 5.41 30.5 ± 19.1 0.530
Social life function 53.2 ± 4.17 39.5 ± 6.04 38.5 ± 12.2 0.204
Mental health 42.2 ± 4.62 39.8 ± 6.26 36.5 ± 14.2 0.869
Data are shown as mean ± standard error
The JOABPEQ comprises five subscales. Higher scores indicate better quality of life
There were statistically significant differences in three JOABPEQ subscale scores [lumbar function, social life function, and mental health (p < 0.05)]. With respect
to pain duration, for patients with chronic pain, there were statistically significant differences in two JOABPEQ subscale scores [lumbar function and mental
health (p < 0.05)]. For patients with subacute or acute pain, there were no statistically significant differences in any of the JOABPEQ subscale scores (p < 0.05)
JOABPEQ Japanese Orthopaedic Association Back Pain Evaluation Questionnaire
aKruskal–Wallis test
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Discussion
The present study demonstrated four major points. (1)
Overall, 58 % of the 102 patients with LBP and/or leg
pain caused by LSS had nociceptive pain, 18 % had
neuropathic pain, and 24 % had an unclear type of pain
(mixed pain) at their first medical examination. (2) NRS
scores for LBP, leg pain, and leg numbness in patients
with LBP and/or leg pain caused by LSS were not signifi-
cantly different among the three pain groups. The RDQ
score in patients with LBP and/or leg pain caused by LSS,
however, was significantly lower in the neuropathic pain
group than in the other groups. (3) Three JOABPEQ sub-
scales (lumbar function, social life function, and mental
health) were significantly lower in the neuropathic pain
group than in the other groups. (4) Two SF-36 subscales
(physical function and bodily pain) were significantly
lower in the neuropathic pain group than in the other
groups.
The statistical power analysis performed in this study
indicated a required total sample size of 102, and the
power was 0.95. Therefore, we believe that the power of
this study was adequate.
LSS may occur at different levels in the spinal canal. It
may be caused by entrapment of nerve roots in the
cauda equina due to hypertrophy of the osseus and soft
tissue structures surrounding the lumbar spinal canal.
Central canal stenosis may compress nerve roots in the
cauda equina, whereas lateral recess stenosis and/or
Table 5 SF-36 score for each pain type at the first medical examination
Parameter Nociceptive pain Type of pain unclear (mixed pain) Neuropathic pain pa
Total patients with pain at first examination
Physical functioning 27.0 ± 2.14 30.2 ± 2.67 21.1 ± 4.73 0.040a
Role physical 33.8 ± 2.15 34.5 ± 3.05 26.5 ± 4.13 0.326
Bodily pain 35.8 ± 0.92 32.5 ± 1.64 29.6 ± 2.53 0.011a
General health 42.4 ± 1.20 41.4 ± 1.99 39.5 ± 2.87 0.668
Vitality 46.3 ± 1.43 41.6 ± 3.01 44.1 ± 2.73 0.396
Social functioning 44.3 ± 1.66 40.5 ± 2.55 37.0 ± 4.53 0.179
Role emotional 40.1 ± 2.16 36.5 ± 3.09 32.4 ± 4.04 0.160
Mental health 46.3 ± 1.40 42.8 ± 2.61 42.1 ± 3.39 0.287
Group with pain present ≥3 months
Physical functioning 25.5 ± 2.58 28.4 ± 3.28 21.9 ± 5.29 0.201
Role physical 32.2 ± 2.86 33.0 ± 4.15 28.2 ± 4.61 0.797
Bodily pain 34.9 ± 1.11 30.9 ± 1.23 31.4 ± 2.96 0.103
General health 42.2 ± 1.42 38.1 ± 1.85 39.8 ± 3.12 0.318
Vitality 45.1 ± 1.72 38.9 ± 3.88 45.0 ± 3.18 0.471
Social functioning 44.1 ± 2.00 39.7 ± 3.24 39.2 ± 5.09 0.473
Role emotional 39.0 ± 2.88 35.1 ± 4.10 34.6 ± 4.49 0.522
Mental health 46.6 ± 1.79 40.0 ± 3.20 44.0 ± 3.64 0.183
Group with pain present <3 months
Physical functioning 30.5 ± 3.80 34.0 ± 4.61 18.2 ± 11.9 0.197
Role physical 37.3 ± 2.60 37.9 ± 3.69 20.4 ± 9.89 0.166
Bodily pain 37.8 ± 1.58 35.9 ± 4.35 23.2 ± 3.55 0.021a
General health 42.7 ± 2.29 48.5 ± 3.87 38.2 ± 7.90 0.335
Vitality 49.2 ± 2.53 47.6 ± 4.12 41.0 ± 5.76 0.494
Social functioning 44.7 ± 3.10 42.3 ± 4.26 29.2 ± 10.2 0.288
Role emotional 42.7 ± 2.68 39.6 ± 4.33 24.7 ± 9.25 0.121
Mental health 45.6 ± 2.19 48.8 ± 3.98 35.2 ± 8.49 0.292
Data are shown as mean ± standard error
The SF-36 comprises eight subscales (score of 0–100). Higher scores indicate better quality of life
There were statistically significant differences in two SF-36 subscale scores [physical function and bodily pain (p < 0.05)]. With respect to pain duration, for
patients with chronic pain, there were no statistically significant differences in any of the SF-36 subscale scores. For patients with subacute or acute pain,
there was a statistically significant difference in one SF-36 subscale score [bodily pain (p < 0.05)]
SF-36 36-Item Short-Form Health Survey
aKruskal–Wallis test
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foraminal stenosis may compress nerve roots but spare
the spine [29, 30]. Although the lower limb symptoms
associated with LSS are mainly attributed to mechano-
receptive compression of nerve rootlets and/or the cauda
equina, they are also associated with inflammation, ische-
mia, malnutrition, nerve degeneration, and nerve injury.
They consequently have a complicated pathophysiology.
The pathological mechanisms of lower limb symptoms
caused by LSS involve nociceptive, inflammatory, and/or
neuropathic pain components, which may result from
postural changes or persistent compression of the nerve
roots and/or cauda equina while walking.
The prevalence of neuropathic pain in the general
population is unclear, although it has been reported at
3–9 % based on the results of various screening ques-
tionnaires in Europe and the United States [31–34]. Few
studies, however, have used the painDETECT to analyze
the pathological mechanisms of LBP and/or leg pain
caused by LSS in primary care-referred patients. Beith
et al. [15] studied patients from southeastern England
who had LBP with or without leg pain and had been re-
ferred for physiotherapy. The authors reported that 59 %
of the patients reported what was identified to be noci-
ceptive pain, 16 % had neuropathic pain, and 25 % had
an unclear type (mixed pain). This result is very similar
to that obtained in the present study of the pathological
mechanisms of LSS-derived LBP and/or leg pain (noci-
ceptive pain, 58 %; neuropathic pain, 18 %; unclear pain
(mixed pain), 24 %). Therefore, our findings may accu-
rately elucidate the pathological mechanisms of LSS-
derived LBP and/or leg pain in the primary care setting.
The NRS scores for LBP, leg pain, and leg numbness
in our patients with LBP and/or leg pain caused by LSS
were not significantly different among the three pain
groups. However, the RDQ score, three JOABPEQ sub-
scale scores (lumbar function, social life function, and
mental health), and two SF-36 subscale scores (physical
function and bodily pain) were significantly lower in the
neuropathic pain group than in the other groups. These
data suggest that the neuropathic pain component
produced significantly lower scores than its non-
neuropathic pain components and reduced the patients’
physical and/or psychological QOL. Therefore, patients
with neuropathic back and/or leg pain caused by LSS
should be diagnosed as soon as possible after referral.
A previous study [35] compared JOABPEQ scores
between patients with LBP who experienced either
neuropathic pain or nociceptive pain as assessed by the
Japanese version of the painDETECT. Their findings
suggest that neuropathic pain affects the social and psy-
chological well-being of patients with LBP and demon-
strate that patients with neuropathic back and/or leg
pain caused by LSS might have particularly low physical
and/or psychological QOL.
Finally it is considered that the impact of this study on
education, health services and research regarding primary
care would suggest that it may be very important to eluci-
date the pathological mechanisms and the epidemiology
of LSS-derived LBP and/or leg pain by classifying the pa-
tients with LSS using painDETECT in order to analyze
either neuropathic pain or non-neuropathic pain, and
this may be helpful to examine how to treatment for
LSS-derived LBP and/or leg pain in primary care setting.
The present study has some limitations that require
attention. First, we studied only a small population,
although we believe that the power was adequate in this
study. Future studies must plan to evaluate a larger
population. Second, this study had a cross-sectional
design—it was not a longitudinal study. We did not
evaluate therapeutic efficacy for LSS in this study.
Hence, future studies should evaluate the therapeutic
efficacy for each pain group caused by LSS, including
conservative versus surgical therapy. Third, it was
considered the lack thorough clinical and laboratory
investigation in this study, since our study utilizes only
questionnaires to classify the pain introduced by LSS.
A clinical study with post-licensure surveillance should
be implemented, ideally by setting up a database that
includes all patients seeking treatment for LBP and/or
leg pain caused by LSS, minimizing losses to follow-up,
and using validated methods to gather clinically relevant
data including demographic information, clinical features,
common co-morbidities, conservative and/or surgical
treatments applied to each patient, experience and
training standards of the care providers applying each
treatment, and each patient’s clinical evolution [36].
Conclusions
It may be important to analyze the pathological mecha-
nisms of neuropathic pain and non-neuropathic pain in
patients with LBP and/or leg pain caused by LSS. Pa-
tients with neuropathic back and/or leg pain caused by
LSS may experience particularly low physical and/or
psychological QOL.
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